Related Experiment Video
Updated: Jun 3, 2026
10:30
Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
Published on: May 24, 2016
PCR techniques for deletion, linkage, and mutation analysis in duchenne/becker muscular dystrophy
1Regional Molecular Genetics Laboratory, Liverpool Women's Hospital, Liverpool, UK.
Methods in Molecular Medicine
|March 5, 2011
Summary
Molecular genetic analysis for Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) is complex due to the large dystrophin gene. Challenges include gene size, numerous exons, large introns, new mutations, recombination, and germline mosaicism.
Area of Science:
- Genetics
- Molecular Biology
- Neuromuscular Disorders
Background:
- Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are allelic genetic disorders.
- These conditions result from mutations within the dystrophin gene.
- The dystrophin gene is exceptionally large (2.4 Mb) with 79 exons and a 14-kb mRNA transcript.
Purpose of the Study:
- To highlight the significant challenges in routine molecular genetic analysis of DMD and BMD.
- To detail the specific genetic and structural factors complicating diagnostic interpretation.
Main Methods:
- Analysis of the dystrophin gene structure, including exon and intron sizes.
- Review of factors contributing to diagnostic complexity.
Main Results:
- The dystrophin gene's large size and complex structure (small exons, large introns) present analytical difficulties.
- High incidence of de novo mutations (approx. 1/3 of DMD cases) complicates diagnosis.
- Increased recombination rates and germline mosaicism further challenge accurate genetic testing.
Conclusions:
- Molecular genetic analysis for DMD and BMD is exceptionally challenging in diagnostic laboratories.
- Gene size, mutation incidence, recombination, and mosaicism are key factors hindering routine analysis.
